CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,653,308
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,653,308. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-21 | Quinlan Paul T General Counsel | Option exercise · Employee Warrant (right to buy) 10b5-1 | −10,000 | 79,996 | ||
| 2026-09-15 | Goncalves Joana Chief Medical Officer | Option exercise 10b5-1 | +3,500 | $6.84 | $24K | 36,218 |
| 2026-09-15 | Goncalves Joana Chief Medical Officer | Option exercise 10b5-1 | +3,500 | $7.80 | $27K | 39,718 |
| 2026-09-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −2,384 | $91.10 | $217K | 37,334 |
| 2026-09-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −3,150 | $92.03 | $290K | 34,184 |
| 2026-09-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −1,366 | $92.99 | $127K | 32,818 |
| 2026-09-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −100 | $94.22 | $9K | 32,718 |
| 2026-09-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −947 | $95.71 | $91K | 31,771 |
| 2026-09-15 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −3,500 | 193,563 | ||
| 2026-09-15 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Warrant (right to buy) 10b5-1 | −3,500 | 164,992 | ||
| 2026-09-15 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −560 | $95.71 | $54K | 14,752 |
| 2026-09-15 | Klein Lawrence Otto Chief Executive Officer | Sale | −2,452 | $95.71 | $235K | 923,128 |
| 2026-09-15 | Quinlan Paul T General Counsel | Sale | −1,039 | $95.71 | $99K | 29,995 |
| 2026-09-15 | Sandler Laura Lee Chief Operating Officer | Sale | −906 | $95.71 | $87K | 235,478 |
| 2026-09-11 | Agarwal Arjun Senior Vice President, Finance | Option exercise 10b5-1 | +8,000 | $12.50 | $100K | 23,312 |
| 2026-09-11 | Agarwal Arjun Senior Vice President, Finance | Option exercise 10b5-1 | +1,459 | $34.39 | $50K | 24,771 |
| 2026-09-11 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −3,000 | $91.11 | $273K | 21,771 |
| 2026-09-11 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −4,051 | $92.41 | $374K | 17,720 |
| 2026-09-11 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −2,208 | $93.26 | $206K | 15,512 |
| 2026-09-11 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −200 | $94.02 | $19K | 15,312 |
Page 4 of 18 · 346 trades